Activity Provided By:

ACHL

T2D Management in Primary Care Practice: Addressing the Weight of it All

Overview / Abstract:	This expert-led activity offers a “how to” method for introducing strategies that support management of both dysglycemia and obesity. This activity highlights the ramifications of untreated obesity in patients with dysglycemia to underscore the importance of early obesity intervention. It also outlines ways to individualize obesity and dysglycemia management, recognize the benefits of earlier treatment intensification and weight loss, understand the latest data with incretin-based therapies, and optimize strategies to achieve sustained weight loss in patients with T2DM. Prior to participating in the activity, we recommend accessing the T2D Digital Tool to assess your ability to manage patients with dysglycemia and obesity. The series of questions is followed by a comparison of performance with peers as well as personalized takeaways and recommendations for modifications to your management of these patients.
Expiration	Mar 15, 2023
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME
Format	Online, Webinar / Webcast / Video
Credits / Hours	.75
Accreditation	ACCME
Presenters / Authors / Faculty	Robert Kushner, MD Professor of Medicine and Medical Education Northwestern University Feinberg School of Medicine Director, Center for Lifestyle Medicine Northwestern Medicine Chicago, IL Donna Ryan, MD Professor Emerita Pennington Biomedical Baton Rouge, LA
Activity Specialities / Related Topics	Endocrinology, Internal Medicine, Primary Care
Sponsors / Supporters / Grant Providers	This activity is supported by an educational grant from Lilly. This activity is sponsored by the Academy for Continued Healthcare Learning (ACHL).
Keywords / Search Terms	ACHL Donna ryan, robert Kushner, T2D, T2DM, diabetes, prediabetes, obesity, clinical inertia, cardiometabolic, cv outcomes, GLP-1, GLP-1 receptor agonist, dpp, pleiotropic, Cardioprotection, Hypoglycemia, glucose, hba1c, Dulaglutide, Exenatide, incretin, MACE, semaglutide, emerging treatment, patient case, Glucagon, Tirzepatide, SURPASS, Glycemic Target, Metformin, Weight Loss, Adherence Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map